Back to Search
Start Over
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials
- Source :
- JAMA Oncology, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname
- Publication Year :
- 2018
- Publisher :
- AMER MEDICAL ASSOC, 2018.
-
Abstract
- This study uses the European Society of Medical Oncology Magnitude of Clinical Benefit Scale to evaluate the clinical benefit of anticancer drugs that gained approval by the US Food and Drug Administration based on single-arm rather than randomized clinical trials.
- Subjects :
- Cancer Research
medicine.medical_specialty
business.industry
United States Food and Drug Administration
Cancer drugs
MEDLINE
Antineoplastic Agents
United States
law.invention
Food and drug administration
03 medical and health sciences
0302 clinical medicine
Oncology
Randomized controlled trial
law
030220 oncology & carcinogenesis
Drug approval
Research Letter
Medicine
Humans
030212 general & internal medicine
business
Intensive care medicine
Drug Approval
Subjects
Details
- ISSN :
- 23742437
- Database :
- OpenAIRE
- Journal :
- JAMA Oncology, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname
- Accession number :
- edsair.doi.dedup.....fe6285896077223b7027fb3de01451e5